FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4293798417> ?p ?o ?g. }

• W4293798417 endingPage "1822" @default.
• W4293798417 startingPage "1822" @default.
• W4293798417 abstract "Chagas disease (CD) is a parasitic zoonosis endemic in Central and South America affecting nearly 10 million people, with 100 million people at high risk of contracting the disease. Treatment is only effective when received at the early stages of the disease and it involved two drugs (nifurtimox (NFX) and benznidazole (BNZ)). Both treatments require multiple daily administrations of high doses, suffer from variable efficacy and insufficient efficacy in chronic CD, many side effects, and a very long duration of treatment that results in poor compliance, while combined available therapies that lead to reduced duration of treatment are not available and polypharmacy reduces compliance and increases the cost further. Here we present self-nanoemulsified drug delivery systems (SNEDDS) able to produce easily scalable combined formulations of NFX and BNZ that can allow for tailoring of the dose and can be easily converted to oral solid dosage form by impregnation on mesoporous silica particles. SNEDDS demonstrated an enhanced solubilisation capacity for both drugs as demonstrated by flow-through studies and in vitro lipolysis studies. High loading of SNEDDS to Syloid 244 and 3050 silicas (2:1 w/w) allowed clinically translatable amounts of both NFX and BNZ to be loaded. Tablets prepared from NFX-BNZ combined SNEDDS loaded on Syloid 3050 silicas demonstration near complete dissolution in the flow through cell apparatus compared to NFX and BNZ commercial tablets respectively (Lampit® and Rochagan®). NFX-BNZ-SNEDDS demonstrated nanomolar efficacy in epimastigotes and amastigotes of T. cruzi with acceptable selectivity indexes and demonstrated enhanced survival and reduced parasitaemia in acute murine experimental models of CD. Thus, the results presented here illustrate the ability for an easily scalable and personalised combination oral therapy prepared from GRAS excipients, enabling treatment access worldwide for the treatment of CD." @default.
• W4293798417 created "2022-08-31" @default.
• W4293798417 creator A5004253180 @default.
• W4293798417 creator A5008337889 @default.
• W4293798417 creator A5009224895 @default.
• W4293798417 creator A5009247707 @default.
• W4293798417 creator A5038813690 @default.
• W4293798417 creator A5060714030 @default.
• W4293798417 creator A5069328902 @default.
• W4293798417 date "2022-08-29" @default.
• W4293798417 modified "2023-10-14" @default.
• W4293798417 title "Solid Nanomedicines of Nifurtimox and Benznidazole for the Oral Treatment of Chagas Disease" @default.
• W4293798417 cites W1964625338 @default.
• W4293798417 cites W1964738990 @default.
• W4293798417 cites W1971958831 @default.
• W4293798417 cites W1972253258 @default.
• W4293798417 cites W1978058209 @default.
• W4293798417 cites W1980249850 @default.
• W4293798417 cites W1991297784 @default.
• W4293798417 cites W1995019226 @default.
• W4293798417 cites W2006037110 @default.
• W4293798417 cites W2011690227 @default.
• W4293798417 cites W2012584860 @default.
• W4293798417 cites W2022258204 @default.
• W4293798417 cites W2022486379 @default.
• W4293798417 cites W2023499226 @default.
• W4293798417 cites W2024484582 @default.
• W4293798417 cites W2025226890 @default.
• W4293798417 cites W2028381865 @default.
• W4293798417 cites W2034695018 @default.
• W4293798417 cites W2045990066 @default.
• W4293798417 cites W2051324369 @default.
• W4293798417 cites W2068300928 @default.
• W4293798417 cites W2071404738 @default.
• W4293798417 cites W2078774051 @default.
• W4293798417 cites W2081425608 @default.
• W4293798417 cites W2083840406 @default.
• W4293798417 cites W2090209033 @default.
• W4293798417 cites W2102786777 @default.
• W4293798417 cites W2125888372 @default.
• W4293798417 cites W2128407714 @default.
• W4293798417 cites W2133362197 @default.
• W4293798417 cites W2147087372 @default.
• W4293798417 cites W2153882192 @default.
• W4293798417 cites W2158793287 @default.
• W4293798417 cites W2254057616 @default.
• W4293798417 cites W2258604996 @default.
• W4293798417 cites W2281175626 @default.
• W4293798417 cites W2297205099 @default.
• W4293798417 cites W2420825806 @default.
• W4293798417 cites W2588740749 @default.
• W4293798417 cites W2763660888 @default.
• W4293798417 cites W2773948814 @default.
• W4293798417 cites W2801364730 @default.
• W4293798417 cites W2805030945 @default.
• W4293798417 cites W2912197610 @default.
• W4293798417 cites W2962064659 @default.
• W4293798417 cites W2965616558 @default.
• W4293798417 cites W2983120443 @default.
• W4293798417 cites W3000083875 @default.
• W4293798417 cites W3018684785 @default.
• W4293798417 cites W3046782568 @default.
• W4293798417 cites W3062649171 @default.
• W4293798417 cites W3128231649 @default.
• W4293798417 cites W3139296993 @default.
• W4293798417 cites W3146533948 @default.
• W4293798417 cites W3161491831 @default.
• W4293798417 cites W4210992500 @default.
• W4293798417 cites W4250677409 @default.
• W4293798417 doi "https://doi.org/10.3390/pharmaceutics14091822" @default.
• W4293798417 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36145570" @default.
• W4293798417 hasPublicationYear "2022" @default.
• W4293798417 type Work @default.
• W4293798417 citedByCount "5" @default.
• W4293798417 countsByYear W42937984172022 @default.
• W4293798417 countsByYear W42937984172023 @default.
• W4293798417 crossrefType "journal-article" @default.
• W4293798417 hasAuthorship W4293798417A5004253180 @default.
• W4293798417 hasAuthorship W4293798417A5008337889 @default.
• W4293798417 hasAuthorship W4293798417A5009224895 @default.
• W4293798417 hasAuthorship W4293798417A5009247707 @default.
• W4293798417 hasAuthorship W4293798417A5038813690 @default.
• W4293798417 hasAuthorship W4293798417A5060714030 @default.
• W4293798417 hasAuthorship W4293798417A5069328902 @default.
• W4293798417 hasBestOaLocation W42937984171 @default.
• W4293798417 hasConcept C112418997 @default.
• W4293798417 hasConcept C136764020 @default.
• W4293798417 hasConcept C178790620 @default.
• W4293798417 hasConcept C185592680 @default.
• W4293798417 hasConcept C203014093 @default.
• W4293798417 hasConcept C2776171842 @default.
• W4293798417 hasConcept C2777625466 @default.
• W4293798417 hasConcept C2779820397 @default.
• W4293798417 hasConcept C2781049234 @default.
• W4293798417 hasConcept C41008148 @default.
• W4293798417 hasConcept C71924100 @default.
• W4293798417 hasConcept C71928629 @default.
• W4293798417 hasConcept C77281830 @default.

• next